Four-ml fractions were collected as described (Pretlow et al., 1975) . The densities of the respective fractions were determined from the refractive indices measured with an Abbe 3L refractometer together with information furnished by Pharmacia Fine Chemicals (Piscataway, NJ, USA). Fractions ranging in density from 1.050 to 1.088gml-l were plated in soft agar. Greater than 95% of the cells in each of these fractions were lymphocytes and monocytes as identified by Haemacolor stain (E.M. Industries, Inc., Gibbstown, NJ, USA). Any fraction with less than a million cells was pooled with the contiguous, denser fraction.
Just prior to addition of the agar to the cells, cell counts were performed with haemocytometer chambers, the ability of the cells to exclude trypan blue was assessed, and the cells were passed through Nitex (TETKO, Inc., Elmsford, NY, USA) with a pore diameter of 48 gm. Cells were plated in 1 ml of medium that consisted of 0.3% agar, 83.2% modified McCoy's medium (Pike & Robinson, 1970) , and 16.5% foetal bovine serum. Cells from each fraction were plated at 1.0, 0.5, and 0.33 x 106ml-1. The underlayer on which the cells were plated consisted of 1 ml of 0.5% agar in the same medium. Cultures were incubated at 37°C in humidified 5% carbon dioxide in air. Cultures were checked within 24h for cell clumping and were then checked periodically for up to 4 weeks. Clumps larger than 4 cells were not observed within the first 24h. Cultures were terminated by fixation with 3% glutaraldehyde and were prepared for light and electron microscopy (Zucker-Franklin & Grusky, 1974) .
Cultures from 5 normal volunteers and 4 of 9 patients with metastatic melanoma exhibited no growth. The cells shrank over a period of 5-10 days. After 3 weeks most of the cells dissolved or appeared refractile and degenerated.
Cells Zucker- Franklin & Grusky (1974) . Cells that contained pigment were common by light microscopy. From three patients, cells in colonies were found that were identifiable as melanocytes ( Figure 2 ) by virtue of the ultrastructural identification of premelanosomes and melanosomes in early stages of melanization such as those described previously in tumours (Seije et al., 1963; Kanzaki et al., 1977; Costa et al., 1973) . Sections of some colonies failed to reveal premelanosomes and melanosomes. When premelanosomes and melanosomes were observed, they were not seen in all sections from the same colony.
Systemic metastases are followed by death in most patients, and haematogenous spread is viewed by many as one of the important early steps in this process (Fidler & Nicolson, 1976; Weiss & Ward, 1983) . Numerous investigators (Engell, 1955; Goldblatt & Nadel, 1965; Circulating Cancer Cell Cooperative, 1962) and were adapted for the assay of antineoplastic drug sensitivity by Hamburger & Salmon (1977) ; Salmon et al. (1978) . Because haematopoietic stem cells have grown in other systems for the culture of cells in soft agar (Chervenick & Boggs, 1971; Kurnick & Robinson, 1971) , we monitored cultures from normal donors for the development of colonies. The fact that no colonies developed from the cells of normal donors and the fact that premelanosomes and melanosomes were identified in some of the colonies that grew from the cells of patients with melanoma lead us to believe that the present culture is selective for the growth of neoplastic cells from blood and against the growth of haematopoietic stem cells.
While the use of the system described here will have many of the same problems in interpretation of data as described for the clonogenic assay (Von Hoff, 1983; Selby et al., 1983) , the procurement of malignant cells from peripheral blood may offer some advantages over the dissociation of cells from solid tumours. The problems of damage to cells during enzymatic and/or mechanical disaggregation of solid tumours will be avoided. Multiple sequential samples may be taken with relatively little trauma during the course of the patient's disease. In obtaining cells from peripheral blood, one may be selecting for subpopulations of cells that are different from those in the primary tumour in their biological capacities.
There have been many reports (Schirrmacher & Waller, 1982; Butler & Gullino, 1975; Glaves, 1983; Mayhew & Glaves, 1984; Liotta et al., 1974; Suzuki, 1984) of the isolation and/or quantification of circulating malignant cells in laboratory animals with experimental, usually transplanted tumours. To our knowledge, this is the first report that suggests that malignant cells can be purified from the peripheral blood of a large proportion of humans with any kind of solid tumour.
The limited (10ml) quantity of blood that we used in our experiments permitted us to grow malignant cells from the blood of 5 of 9 patients with metastatic malignant melanoma; this observation suggests many other experiments that might be accomplished with larger numbers of cells. Additional work with larger quantities of blood will be required to characterize circulating malignant melanoma cells, i.e. to investigate their true cloning efficiency, to determine if subpopulations of malignant cells with different cloning efficiencies or other differences might be identified in different fractions of density gradients. Immunological probes would facilitate one approach to determining the proportion of cells plated that are actually melanoma cells; this information would be required before one could inquire about the 'real' cloning efficiency of circulating, malignant melanocytes. Since none of the blood donors had tumours on their extremities distal to the anticubital fossa, it is likely that the malignant cells in our samples of blood were highly selected and representative only of cells that survived filtration by both the pulmonary and distal capillary beds. It would be interesting to compare these cells with those derived from (a) veins that drain tumours, (b) disaggregation of solid tumours, and (c) disaggregation of metastases. The varied consequences of different methods for obtaining malignant cells in suspension from solid tumours have been discussed previously .
The immediate problem with the use of peripheral blood for the tumour stem cell assay is the collection of sufficient numbers of cells. To date, we have used only 10ml samples, only isopycnic centrifugation and culture in soft agar as selective methods, and only cells from patients with metastatic melanoma. One would anticipate that larger volumes of blood and additional methods for the purification of malignant cells reviewed by us previously (Pretlow & Pretlow, 1982 would enhance one's ability to obtain larger numbers of colonies. PITTS, A.M. (1977) 
